Healio (11/23, Gramigna) reports, “Ketamine improved neurocognitive outcomes at 24 hours among patients with depression and suicidal ideation,” investigators concluded in a “randomized trial that compared ketamine with midazolam among 78 patients with depression who had clinically significant suicidal ideation.” The findings were published online Nov. 2 in the Journal of Clinical Psychiatry. (SOURCE: APA Headlines)